Bruker (BRKR) Partners With NovAliX to Boost Drug Discovery
ZacksBruker (BRKR) invests in NovAliX to accelerate advancements in drug discovery, combining cutting-edge biophysical methods and technologies to develop new treatments and enhance biopharma solutions.